Disorders of hemostasis in small animals

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/87

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

88 Terms

1
New cards

Hemostasis definition

Stopping the flow of blood

2
New cards

Reduced hemostasis results in what?

Bleeding

3
New cards

Increased hemostasis results in what?

Thrombosis

4
New cards

Primary hemostasis problems center around what part of the clotting process?

Formation of the platelet plug

5
New cards

Secondary hemostasis problems center around what part of the clotting process?

Stabilization of the platelet plug

6
New cards

Tertiary hemostasis problems center around what part of the clotting process?

Breakdown of the platelet plug

7
New cards

Primary hemostasis problems can result from disorders of what cellular factors?

Vascular endothelium, platelets, von Willerbrand factor

8
New cards

Secondary hemostasis problems can result from disorders of what cellular factors?

Fibrin formation, coagulation proteins/factors, intrinsic and extrinsic clotting cascades

9
New cards

Tertiary hemostasis problems can result from disorders of what cellular factors?

Fibrinolysis, Plasmin

10
New cards

What bleeding disorders impact the primary hemostasis step?

Thrombocytopenia, thrombocytopathia, Von Willerbrand’s Disease, Vasculopathies

11
New cards

What bleeding disorders impact the secondary hemostasis step?

Anticoagulant rodenticide toxicity, liver failure, congenital factor deficiencies (hemophilia for example)

12
New cards

What bleeding disorders impact the tertiary hemostasis step?

Hyperfibrinolysis

13
New cards

What are complex or “mixed” disorders involving multiple aspects of hemostasis?

Disseminated intravascular coagulation, angiostrongylus vasorum infection, sepsis, trauma associated coagulopathy

14
New cards

Thrombocytopenia is often associated with what clinical signs?

Petechiation and ecchymoses, epistaxis, GI bleeding (may result in melaena), Signs associated with hemorrhagic anemia thrombocytopenia may also be noted on hematology

15
New cards

Von Willerbrand’s disease is often associated with what clinical signs?

Prolonged bleeding at surgical sites, prolonged bleeding at estrus, other signs associated with hemorrhagic anemia

16
New cards

Coagulopathies are often associated with what clinical signs?

Hematoma formation, hemarthrosis, pulmonary hemorrhage, bleeding into body cavities, other signs associated with hemorrhagic anemia

17
New cards

What laboratory assessments can determine a problem in the primary hemostasis phase?

Platelet count, buccal mucosal bleeding time

18
New cards

What laboratory assessments can determine a problem in the secondary hemostasis phase?

Prothrombin time, activated partial thromboplastin time, Fibrinogen

19
New cards

What laboratory assessments can determine a problem in the tertiary hemostasis phase?

Fibrin-degradation products FDPs, D-dimers, TEG/ROTEM

20
New cards

What platelet counts are considered concerning (RI 200-500)?

<50 × 10^9/l

21
New cards

What is considered an adequate platelet count per x100 high power field?

10-15

22
New cards

Buccal mucosal bleeding time is used to assess what?

Platelet funciton, vascular response to injury, adequacy of vWF

23
New cards

Why should you do a platelet count before performing a buccal mucosal bleeding time?

Thrombocytopenia will also result in prolonged times and easier to check!

24
New cards

When should buccal mucosal bleeding cease?

2-4 min

25
New cards

What breeds are predisposed to congenital bleeding disorders?

German Shepherd Dogs, Doberman Pinschers

26
New cards

Why would a patients deworming history be prevalent in a bleeding disorder presentation?

Angiostrongylus vasorum for example

27
New cards

What tests can be used to evaluate secondary hemostasis?

Standard Coagulation tests: Prothrombin time and activated partial thromboplastin time

28
New cards

Prothrombin time test can show disorders in what factors/components of clotting?

Extrinsic and Common pathways, Factor VII

29
New cards

Activated partial thromboplastin time testing can show disorders in what factors/components of clotting?

Intrinsic and common pathway, Factors IX and VIII

30
New cards

Platelet count of <30 × 10^9/l is associated with what?

Spontaneous bleeding

31
New cards

Why have we moved away from activated clotting time tests?

Clotting factors have to be very low before the time is prolonged, test lacks sensitivity

32
New cards

Laboratory only evaluation of tertiary hemostasis tests include

D-dimers and Fibrin degredation products

33
New cards

What are potential causes of epistaxis?

Hemostatic disorders, nasal tumors, aspergillosis, nasal foreign body, hypertension

34
New cards

What are potential causes of hemoabdomen?

Hemostatic disorder, trauma, neoplasia (splenic, hepatic, or vena cava involvement)

35
New cards

What bleeding disorders are acquired disorders?

Thrombocytopenia, thrombocytopathia, vasculopathies, anticoagulant rodenticide toxicity, liver failure, hyperfibrinolysis

36
New cards

What is the most common cause of thrombocytopenia?

Immune mediated thrombocytopenia

37
New cards

If you suspect bone amrrow failure, what tests should be done?

Look for other cytopenias, perform bone marrow evaluation

38
New cards

What test/result will lead you to consider a patient ahs an increased consumption (ex severe blood loss)?

Changes on coagulation profile

39
New cards

What is the average signalment of immune mediated thrombocytopenia?

Median age of 4-5 years, Cocker Spaniels seem predisposed

40
New cards

What are the presenting signs of immune mediated thrombocytopenia?

Primary hemostatic disorder, ex surface/capillary bleeding

41
New cards

How do we diagnose immune mediated thrombocytopenia?

Very low platelets, demonstration of thrombocytopenia, diagnosis of exclusion → this diagnosis

42
New cards

How should we manage an immune-mediated thrombocytopenic patient?

Gentle handling, blood transfusion if severely anemic, treat underlying trigger if applicable, immunosuppression, offer vincristine

43
New cards

What can vincristine doe for our bleeding disorder patients?

Increases number of circulating platelets (in an effort to reduce hospitalization times)

44
New cards

How do anticoagulant rodenticides lead to bleeding disorders?

They inhibit Vit K recycling → reduced active clotting factors II, VII, IX, and X

45
New cards

How do we diagnose anticoagulant rodenticide toxicity?

History of potential exposure within preceding 2-3 days, signs compatible with coagulopathy (ex bleeding into body cavities, hematomas)

Frequently present with signs of blood loss, anemia and/or hypovolemia

46
New cards

What lab tests can help diagnose anticoagulant rodenticide toxicity?

prolonged PT and aPPT, reduced platelet count, anemia (pre regenerative or regenerative)

47
New cards

What is the treatment for anticoagulant rodenticide toxicity if ingestion is known to be <6 hours ago?

Emesis, decontamination, monitor PT up to 48 h post ingestion

48
New cards

What is the treatment for anticoagulant rodenticide toxicity if patient is presenting with clinical signs?

SQ Vit K1 for 24-48 hours if bleeding, then oral

Supportive care: Thoracocentesis only if dyspneic from pleural effusion, Transfusion of whole blood if severe anemia, Fresh frozen plasma to replace factors

49
New cards

How can severe/chronic liver disease lead to hematological conditions?

Cholestasis → failure of Vit K absorption → clotting disorders

50
New cards

How does end-stage liver disease lead to hematologic disorders?

Reduced production of clotting factors

AND

Reduced activation of vit K dependent factors

51
New cards

What are clinical signs of liver disease?

Coagulopathy: expect cavity bleeds

Spontaneous bleeding uncommon except in fulminant acute liver failure

Increased bleeding risk with biopsy**

52
New cards

What lab test can aid diagnosis of liver disease as a cause of coagulopathy?

Prolongation of PT and aPTT, concurrent signs of liver/cholestatic disease

Including: Increased liver enzymes, increased bilirubin and/or bile acids, reduced albumin, reduced urea

53
New cards

What is the treatment for liver disease causing coagulopathies?

Supportive treatment for liver disease, Vit K supplementation prior to biopsy, Plasma to replenish coagulation factors

54
New cards

What cardiorespiratory signs can present from an angiostrongylus vasorum infection?

Cough, dyspnea, syncope, harsh lung sounds, exercise intolerance

55
New cards

What hemostatic signs can present from an angiostrongylus vasorum infection?

Epistaxis, conjunctival hemorrhage, prolonged surgical bleeding, bleeding into any body cavity, hemoptysis, petechiae/ecchymoses

56
New cards

What neurological signs can present from an angiostrongylus vasorum infection?

Paralysis, seizures, ataxia, weakness, proprioceptive deficits

57
New cards

How can we diagnose angiostrongylus vasorum infection?

Clinical presentation (including regional variations), tests of hemostasis including for low fibrinogen, thrombocytopenia, and prolonged PT and/or aPPT

Fecal Baermann’s test/fecal wet prep/ ELISA:IDEXX

58
New cards

Why may lab tests be normal in dogs that are actively bleeding?

Hyperfibrinolysis

59
New cards

How can we treat Angiostrongylus Vasorum infections?

Supportive care for hemorrhage, kill parasites, consider steroids

60
New cards

What licensed anthelmintics are capable of killing “lung worms?”

Imidacloprid/moxidectin and milbemycin

61
New cards

Why might steroids be used in lung worm infections?

For ‘worm kill’ effect, suppresses inflammatory/anaphylactic reactions as the worms die to other medications

62
New cards

How can we treat bleeding as a result of angiostrongylus vasorum infeciton?

Tranexamic Acid 

63
New cards

How does Tranexamic acid help control bleeding in lung worm infections?

Reduces activation of plasmin by binding to lysine receptors. End result is inhibiting fibrinolysis

64
New cards

What is Disseminated Intravascular Coagulation?

Widespread of activation of the coagulation pathway ins the presence of an underlying disease

65
New cards

Why does DIC occur?

Widespread endothelial damage/release of tissue thromboplastins secondary to neoplastic, inflammatory, or infectious disease and/or a variety of misc conditions

66
New cards

What are clinical signs of DIC?

Mixture of thrombosis and bleeding (compensated condition may not be associated with active hemorrhage)

67
New cards

How can we diagnose DIC?

Increased aPTT and/or PT, Thrombocytopenia (consumptive), decreased fibrinogen, increased FDPs and D-dimer

68
New cards

What is the prognosis for DIC?

Poor- hopeless

69
New cards

How can we treat DIC?

Eliminate the initiating cause, ensure adequate tissue perfusion, support target organs susceptible to microthrombi, ischemia or hemorrhage

Replacement of blood components

70
New cards

What is thrombocytopathia?

Platelet dysfunction - rare

71
New cards

When does thrombocytopathia occur?

Associated with an underlying disease process (infectious, systemic, drugs)

72
New cards

What diagnostic tests can be used to identify thrombocytopathia?

Normal PLT count, normal standard coagulation tests, prolonged BMBT, PFA/platelet aggregometry if available

73
New cards

How can we manage thrombocytopathia?

Supportive care, treat underlying disease if possible

74
New cards

What Bleeding disorders can be congenital?

Thrombocytopathia, Von Willerbrand’s disease, Congenital factor deficiencies, hyperfibrinolysis

75
New cards

What is Von Willerbrand’s disease?

Patients have a reduced concentration or function of ____ factors, breed dispositions

76
New cards

What clinical signs are seen in Von Willerbrand’s disease?

Excessive hemorrhage with trauma or surgery

77
New cards

How can we diagnose Von Willerbrand’s Disease?

Normal PLT and coagulation tests, Prolonged BMBT, testing for reduced vWF (<50%=affected)

78
New cards

How do we treat V W disease?

DDAVP (artificial factors) and cryoprecipitate. Palliative care

79
New cards

What clotting factor does Hemophilia A effect?

Factor VIII

80
New cards

What clotting factor does Hemophilia B effect?

Factor IX

81
New cards

What clotting factor does Hageman factor deficiency effect?

Factor XII

82
New cards

Clinical signs/presentations of clotting factor deficiencies all generally present how?

Variably

83
New cards

Features of Hemophilia A and B include

Prevalence in young <1yo animals, X linked recessive, prolonged aPTT, normal PT

84
New cards

Features of Hageman trait include

Cats, typically asymptomatic, prolonged aPTT, normal PT

85
New cards

What treatment can be used for inherited coagulation factor deficiencies?

Transfusion support

86
New cards

What is hyperfibrinolysis?

Excessive breakdown of fibrinogen, suspected cause for increased bleeding in greyhounds

87
New cards

How can we test for hyperfibrinolysis?

FDPs, D-dimers, TEG or ROTEM

88
New cards

How can we treat hyperfibrinolysis?

Supportive care ± transfusions

Tranexamic acid